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Summary: The purpose of this study was to detect the possibility of drug interference in the estimation of
urine protein in patients receiving therapeutic doses of penicillin G, ampicillin, methicillin, cefoxitin, cefazolin,
gentamicin, co-trimoxazole, phenothiazines, glibenclamide and acetazolamide. Five different methods for
urine protein determination were compared in these patients, when different amounts of albumin were added
to urine in vitro, and in a control group of patients not treated witfi drugs known to interfere with these
methods. The techniques included two semi-quantitative tests — a strip test (Albustix) and heat and acetic
acid turbidity test; and three quantitative tests — sulphosalicylic acid test, trichloroacetic acid test and a test
based on a formation of Ponceau S dye-protein complex (Urin-Pak).
The only significant interference found was that of gentamicin with the Ponceau S dye test.
Interferenz von Arzneimitteln mit der Bestimmung von Proteinen im Harn
Zusammenfassung: Die Bestimmung von Protein im Harn sollte hinsichtlich möglicher Interferenzen bei
Patienten geprüft werden, die therapeutische Dosen von Penicillin G, Ampicillin, Methicillin, Cefoxitin,
Cefazolin, Gentamicin, Co-trimoxazol (Trimethoprim/Sulfamethoxazol), Phenothiazine, Glibenclamid und
Acetazolamid erhielten. Am Harn dieser Patienten wurden 5 verschiedene Methoden zur Proteinbestimmung
verglichen, indem unterschiedliche Mengen von Albumin in vitro zum Harn hinzugefügt wurden." Als
Kontrollen dienten Harne von Patienten, die nicht mit Arzneimitteln, von denen Interferenzen mit den
Methoden bekannt waren, behandelt wurden.
Die Methoden umfaßten zwei halbquantitative Tests: einen Streifentest (Albustix) und den Hitze/Essigsäure-
Trübungstest sowie drei quantitative Tests: Sulfosalicylsäuretest, Trichloressigsäuretest und einen Test auf
Grundlage der Bildung eines Ponceau S Farbstoff-Protein-Komplexes (Urin-Pak).
Die einzige signifikante Interferenz wurde für Gentamicin mit dem Ponceau S Farbstofftest gefunden.
Introduction amides, sulphonylureas) and the relevance to newly
_. . , - . , j * · * r -^ introducedagentsofthesamefamilyremainsinques-Vanous drugs have been reported to interfere with 4. ™ r *u· * * rf , - . . ,4^ tion. The purpose of this study was to compare fivevanous methods of urine protein measurement (1). ,.rr * *if j r *u *· *· r · * ·
TT _ t * V different methods for the estimation of urine proteinHowever, many of these reports were based on m ~ . , « . .. . . .~ « - « j ..' u which are used m climcal practicevitro studies and with drug concentrations above
those nörmally achieved in clinical practice, thus the a) in vitro,
elinical significance of these interferenees is not al- b) in a control group of patients, and
ways clear. Moreover, the interfering agents äs re- c) in patients receiving therapeutic doses of various
ported in many cases in the literature, were designated medications suspected, according to the literature,
by the family of drugs (e. g., cephalosporins, sulphon- to interfere with at least one of the methods.
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It was assumed that albuininuria caused by disease
or by a nephrotoxic effect of a drug would be detected
by all methods, whereas false albuminuria caused by
a drug interference with the methodology of a test
would be recognised by significantly different values
from the different methods. No single method can be
considered s a reference test, since the techniques
employed may respond differently to different types
of protein and may be interferred with by high con-
centration of urinary pigments.
Materials and Methods
TKe five different tests for the estimation of urine protein were
c rried out according to published procedures. The tests were
s follows:
A. Tvvo serai-quantitative tests:
1. A strip test - "Albustix" (2),
2. Heat and acetic acid turbidity test (3).
B. Three quantitative tests:
1 . Sulphosalicylic acid test (4),
2. Trichloroacetic acid test (5),
3. Ponceau S dye-protein complex test - "Urin-Pak" (6, 7).
All readings were made by one observer. All the analyses were
done on the same urine samples.
The upper limit of "normal" urinary protein for Ponceau S dye
was 0.3 g/l and 0.15-0.2 g/l for the other four methods.
In vi tro studies
Albumin (Albumin human 4X Crystalline, Nutritional Bio-
chemicals Corporation, Cleveland, Ohio) in concentrations of
0, 0.1, 0.5 and 1.0 g/l was added to urine samples of one healthy
volunteer on different days. The samples were then analysed
for protein in order to determine the precision of each method
and to compare the methods. These protein estimates were
not used for calculation of protein concentrations in patients.
Patient protein concentrations were calculated from separate
Standard e rves, or from an albumin Standard run in each day
of analysis according to the method's published instructions.





























1.5 or 2.0 g χ 4
1500000 or
3000000 χ 4
1.5 or 2.5 g χ 4
5 mg χ 1 or 2
250mg χ 3


























































































Seventy nine hospitalized adult patients receiving parenterally
therapeutic doses of the following medications: penicillin G*
ampicillin, methicillin, cefoxitin, cefazolin, and gentamicin; and
orally therapeutic doses of co-trimoxazole, phenothiazines,
(chlorpromazine or trifluoperazine), glibenclaffiide and aceta-
zolamide. Details about dosage schedule and duration of treat-
ment are given in table 1. Patients who had received radio-
opaque dyes which could interfere with some methods or with
a disease like multiple myeloma or conditions which could cause
excretion of proteins other than albumin, were not included in
the study. None of the various other medications received
by the patients was reported to interfere with urine protein
determination.
Mode of urine collection
On the day before urine collection, patients were given a dispos-
able Container and were instructed to void into it their first
urine speciraen, between 7 and 8 hours in the morning. pH was
determined immediately upon collection of the samples and
they were refrigerated until half an hour before protein meas-
urement, later the same day. Different aliquots of urine were
taken from the specimens depending on the test procedure.
They ranged from 0.1 ml for the Ponceau S dye test to 5ml
for the he t and acetic acid test.
Control group
Sixteen hospitalized adult patients not receiving any of the
above medications or other medications known to affect urine
protein determination.
Statistics
Urine protein values obtained by the different methods were
compared by a method of analysis of variance with repeated
raeasurements (8), using the BDMP program (9). When it was
found that at least one significant difterence between two paired
means exists (p < 0.05), a further analysis with t test for paired
samples was carried out to identify the significantly different
pair. ; Ϊ
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Results and Discussion
Comparison of the methods in vitro
Table 2 demonstrates that the 3 quantitative methods
for the estimation of urine protein are comparable.
No significant difference among the mean values ob-
tained with these methods was found when 0, 0.1 and
0.5 g/l of albumin were added. There was however,
a tendency for the Ponceau S dye method to give
false positive values in urine to which no protein was
added and a tendency of the sulphosalicylic acid
method to give higher readings with l .0 g/l of albumin
(mean 1.05 versus 0.96 for trichloroacetic acid and
0.95 for Ponceau S dye, P < 0.05). The Ponceau S
dye method was the most precise at this protein level
(CV = 4.3%).
Comparison of the methods in control group
The means of urine protein by the sulphosalicylic
acid, trichloroacetic acid and Ponceau S dye methods
in the control group of patients did not differ signifi-
cantly P > 0.05. The difference did not vary even
when the 3 patients with grades 2 and 3 of protein,
äs determined by the semi-quantitative methods, were
excluded from analysis.
Comparison of the methods in patients re-
ceiving certain medications
The means of the determinations of urine protein
values in patients receiving ampicillin, cefazolin, cef-
oxitin, co-trimoxazole and methicillin (in combina-
tion with penicillin G or glibenclamide), were not
found to be statistically different in the 3 quantitative
methods. As can be seen in table 3, in patients receiv-
ing therapeutic doses of acetazolamide, glibencl-
amide, penicillin G and phenothiazines, urine protein
determination by the 3 quantitative methods differed
significantly.
The differences arose from the Ponceau S dye method
(c), which gave higher readings than those obtained
by the sulphosalicylic acid method (a), or (except
for the cases of glibenclamide and gentamicin) the
trichloroacetic method (b). Most of the protein con-
centrations in the urine sample of patients receiving
these drugs remained in the 0—0.15 g/l ränge and
thus the differences cannot be considered clinically
relevant. There were few individual concentrations
exceeding this ränge up to 0.25 g/l by the Ponceau S
dye method, but this still remained within the upper
limit of "normal" urinary protein for this method.
This does not exclude relevant clinical differences in
patients with proteinuria.









































































* NS = Not significant
Tab. 3. Mean and Standard deviatipn of urine protein (g/l) measurements by sulphosalicylic acid, trichloroacetic acid and Ponceau












































<0.05 (a, c; b, c)*
<0.01 (a, c)
<0.01 (a, c; b, c)
<0.01 (a, c; b, c)
<0.05 (a, c)
<0.01 (a, c; b, c)
* The a, b, c, indices indicate the corresponding comparisons.
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Gentamicin was the only drug which caused a rele-
vant statistical and clinical effect leading to a reading
of very high values of protein by the Ponceau S dye
method. This verifies the results of Lievens & Celis
(10) who studied the possible interference of gentami-
cin with the Ponceau S dye method. They found
that at therapeutic concentrations gentamicin gave
an apparent proteinuria with protein-free urine and
increased the results by a factor of 2 to 4 when
proteins were present. They did not find interference
of gentamicin with a turbidimetric method, using
sulphosalicylic acid or trichloroacetic acid. Lievens &
Celis suggested that the precipitation of an insoluble
salt of aminoglycosides with Ponceau S dye is the
cause of the interference. They were able to eliminate
the interference by changing the method slightly, pre-
cipitating urinary proteins first with trichloroacetic
acid without Ponceau S dye (instead of with a mixture
of the two), discarding the supernatant and then
carrying out the original procedure on the precipi-
tated protein redissolved in NaOH.
None of the semi-quantitative methods was found to
be affected by the drugs under stucjy. Particularly
noteworthy is the lack of effect of a drug eausing
alkaluria (acetazolamide) on urine protein estimation
by the Albustix method. This test is known to give
false positive results in a very alkaline urine (11),
however, none of the patients had a urine pH of
10 or above. We cpnclüde that methods other than
Ponceau S dye for estimating urine protein shouid be
used in patients receiving gentamicin therapy. Penicil-
lin G, co-trimoxazole, glibenclanaide, acetazolamide
and phenothiazines, contrary to suggestions in litera-
ture (1), were not shown to have a clinically relevant
effect on any of the studied tests.
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